Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 4Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Rectal Neoplasms 51Stomach Neoplasms 45Esophageal Neoplasms 42Colorectal Neoplasms 37Pancreatic Neoplasms 31Carcinoma, Hepatocellular 19Esophageal Squamous Cell Carcinoma 16Colonic Neoplasms 16Adenocarcinoma Of Esophagus 12Neoplasms 7Cholangiocarcinoma 6Peritoneal Neoplasms 4Neoplasm Metastasis 4Recurrence 3Liver Neoplasms 3Gastrointestinal Stromal Tumors 3Clinical Stage I Gastric Cancer AJCC v8 3Cirrhosis, Familial, with Pulmonary Hypertension 3Adenocarcinoma 3Pancreatic Intraductal Neoplasms 2Ovarian Neoplasms 2Neoplastic Cells, Circulating 2Lymphatic Metastasis 2Biliary Tract Neoplasms 2Turcot syndrome 1Tissue Adhesions 1Therapeutic Value of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor 1Stomach Diseases 1Solid Pseudopapillary Neoplasm of the Pancreas 1Sleep Apnea Syndromes 1

Interventions

Gemcitabine 113Cisplatin 77Oxaliplatin 46pembrolizumab 35Fluorouracil 33Capecitabine 31durvalumab 27Leucovorin 27lenvatinib 26Magnetic Resonance Spectroscopy 15Irinotecan 14Drug Therapy 13Biopsy 13Nivolumab 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11130-nm albumin-bound paclitaxel 11pemigatinib 10apatinib 10Taxes 10Radiotherapy 10Floxuridine 10Folfox protocol 9Bevacizumab 9S 1 (combination) 8Platinum 8Photochemotherapy 8Liver Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Surgical Procedures, Operative × Gastrointestinal × Clear all
NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

Shanghai Zhongshan Hospital

Phase NA Not yet recruiting
270 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06721286 2024-12-06

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
70 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06369480 2024-04-17

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

Rigshospitalet, Denmark

Unknown
2,000 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT05672537 2023-01-05

Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
70 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT02103179 2014-04-03

VEGF ECC

First Affiliated Hospital, Sun Yat-Sen University

Unknown
20 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT01917370 2013-08-06

icc

First Affiliated Hospital, Sun Yat-Sen University

Unknown
20 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡